Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia II. Systemic but not local IgA responses correlate with clearance of HPV-16

被引:90
作者
Bontkes, HJ
de Gruijl, TD
Walboomers, JMM
Schiller, JT
Dillner, J
Helmerhorst, TJM
Verheijen, RHM
Scheper, RJ
Meijer, CJLM
机构
[1] Free Univ Amsterdam Hosp, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Obstet & Gynaecol, NL-1007 MB Amsterdam, Netherlands
[3] NCI, Cellular Oncol Lab, Div Basic Sci, Bethesda, MD 20892 USA
[4] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
关键词
D O I
10.1099/0022-1317-80-2-409
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance, However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P= 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007), As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 27 条
  • [1] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [2] BRAUN L, 1990, CANCER RES, V50, P7324
  • [3] Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome
    de Gruijl, TD
    Bontkes, HJ
    Walboomers, JMM
    Coursaget, P
    Stukart, MJ
    Dupuy, C
    Kueter, E
    Verheijen, RHM
    Helmerhorst, TJM
    Duggan-Keen, MF
    Stern, PL
    Meijer, CJLM
    Scheper, RJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 399 - 408
  • [4] Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia
    deGruijl, TD
    Bontkes, HJ
    Walboomers, JMM
    Schiller, JT
    Stukart, MJ
    Groot, BS
    Chabaud, MMR
    Remmink, AJ
    Verheijen, RHM
    Helmerhorst, TJM
    Meijer, CJLM
    Scheper, RJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) : 630 - 638
  • [5] Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
    Dillner, J
    Kallings, I
    Brihmer, C
    Sikstrom, P
    Koskela, P
    Lehtinen, M
    Schiller, JT
    Sapp, M
    Mardh, PA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) : 1394 - 1398
  • [6] Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
    Elfgren, K
    Bistoletti, P
    Dillner, L
    Walboomers, JMM
    Meijer, CJLM
    Dillner, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) : 937 - 942
  • [7] HALPERT R, 1986, OBSTET GYNECOL, V68, P251
  • [8] DETECTION OF DNA AND E7 TRANSCRIPTS OF HUMAN PAPILLOMAVIRUS TYPE-16, TYPE-18, TYPE-31 AND TYPE-33, TGF-BETA AND GM-CSF TRANSCRIPTS IN CERVICAL CANCERS AND PRECANCERS
    HO, L
    TERRY, G
    MANSELL, B
    BUTLER, B
    SINGER, A
    [J]. ARCHIVES OF VIROLOGY, 1994, 139 (1-2) : 79 - 85
  • [9] HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
  • [10] *IARC, 1995, MON EV CARC RISKS HU, V64